TABLE 3b. Estimated percent for time since first diagnosis among adults1 with active2 asthma by state/territory – BRFSS Asthma Call-back Survey Land Line Sample, United States, 2012
State/Territory | Sample size± |
5 or fewer years | More than 5 years | ||||||
---|---|---|---|---|---|---|---|---|---|
Sample size |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | ||
Alabama | 274 | 35 | 14.4 | 3.5 | (7.5 – 21.3) | 239 | 85.6 | 3.5 | (78.7 – 92.5) |
Arizona | 231 | 26 | N/A | N/A | (N/A – N/A) | 205 | 92.8 | 2.6 | (87.7 – 97.9) |
California | 334 | 44 | 10.5 | 2.3 | (6.0 – 15.0) | 290 | 89.5 | 2.3 | (85.0 – 94.0) |
Connecticut | 254 | 36 | 20.0 | 4.7 | (10.8 – 29.2) | 218 | 80.0 | 4.7 | (70.8 – 89.2) |
District of Columbia | 107 | 11 | N/A | N/A | (N/A – N/A) | 96 | 77.2 | 11.1 | (55.4 – 99.0) |
Florida | 234 | 40 | N/A | N/A | (N/A – N/A) | 194 | 78.0 | 7.1 | (64.1 – 91.9) |
Georgia | 159 | 25 | 10.4 | 2.8 | (4.9 – 15.9) | 134 | 89.6 | 2.8 | (84.1 – 95.1) |
Hawaii | 154 | 15 | N/A | N/A | (N/A – N/A) | 139 | 86.3 | 4.7 | (77.1 – 95.5) |
Illinois | 219 | 31 | N/A | N/A | (N/A – N/A) | 188 | 85.0 | 7.0 | (71.3 – 98.7) |
Indiana | 263 | 38 | 12.4 | 2.9 | (6.7 – 18.1) | 225 | 87.6 | 2.9 | (81.9 – 93.3) |
Iowa | 201 | 29 | 14.7 | 4.3 | (6.3 – 23.1) | 172 | 85.3 | 4.3 | (76.9 – 93.7) |
Kansas | 407 | 47 | 10.0 | 2.7 | (4.7 – 15.3) | 360 | 90.0 | 2.7 | (84.7 – 95.3) |
Louisiana | 270 | 34 | N/A | N/A | (N/A – N/A) | 236 | 83.4 | 6.8 | (70.1 – 96.7) |
Maine | 229 | 23 | N/A | N/A | (N/A – N/A) | 206 | 85.1 | 4.7 | (75.9 – 94.3) |
Massachusetts | 229 | 28 | 11.1 | 2.9 | (5.4 – 16.8) | 201 | 88.9 | 2.9 | (83.2 – 94.6) |
Michigan | 490 | 70 | 15.7 | 3.0 | (9.8 – 21.6) | 420 | 84.3 | 3.0 | (78.4 – 90.2) |
Mississippi | 263 | 28 | 8.8 | 2.6 | (3.7 – 13.9) | 235 | 91.2 | 2.6 | (86.1 – 96.3) |
Missouri | 238 | 33 | N/A | N/A | (N/A – N/A) | 205 | 87.3 | 3.9 | (79.7 – 94.9) |
Montana | 291 | 39 | 10.6 | 2.4 | (5.9 – 15.3) | 252 | 89.4 | 2.4 | (84.7 – 94.1) |
Nebraska | 524 | 61 | 8.6 | 1.6 | (5.5 – 11.7) | 463 | 91.4 | 1.6 | (88.3 – 94.5) |
Nevada | 158 | 18 | N/A | N/A | (N/A – N/A) | 140 | 91.1 | 3.2 | (84.8 – 97.4) |
New Hampshire | 286 | 27 | N/A | N/A | (N/A – N/A) | 259 | 86.1 | 4.4 | (77.5 – 94.7) |
New Jersey | 407 | 52 | 13.0 | 2.6 | (7.9 – 18.1) | 355 | 87.0 | 2.6 | (81.9 – 92.1) |
New Mexico | 310 | 41 | 14.6 | 3.5 | (7.7 – 21.5) | 269 | 85.4 | 3.5 | (78.5 – 92.3) |
New York | 189 | 30 | N/A | N/A | (N/A – N/A) | 159 | 84.7 | 5.0 | (74.9 – 94.5) |
North Carolina | 176 | 19 | N/A | N/A | (N/A – N/A) | 157 | 92.6 | 3.2 | (86.3 – 98.9) |
North Dakota | 149 | 25 | N/A | N/A | (N/A – N/A) | 124 | 78.8 | 7.3 | (64.5 – 93.1) |
Ohio | 414 | 79 | 20.7 | 5.5 | (9.9 – 31.5) | 335 | 79.3 | 5.5 | (68.5 – 90.1) |
Oklahoma | 217 | 32 | 12.2 | 3.4 | (5.5 – 18.9) | 185 | 87.8 | 3.4 | (81.1 – 94.5) |
Oregon | 226 | 31 | N/A | N/A | (N/A – N/A) | 195 | 82.4 | 5.3 | (72.0 – 92.8) |
Pennsylvania | 620 | 102 | 12.7 | 2.3 | (8.2 – 17.2) | 518 | 87.3 | 2.3 | (82.8 – 91.8) |
Rhode Island | 192 | 18 | N/A | N/A | (N/A – N/A) | 174 | 84.5 | 5.7 | (73.3 – 95.7) |
Texas | 222 | 40 | N/A | N/A | (N/A – N/A) | 182 | 75.6 | 9.5 | (57.0 – 94.2) |
Vermont | 249 | 29 | 9.7 | 2.7 | (4.4 – 15.0) | 220 | 90.3 | 2.7 | (85.0 – 95.6) |
Washington | 492 | 51 | 14.2 | 3.5 | (7.3 – 21.1) | 441 | 85.8 | 3.5 | (78.9 – 92.7) |
West Virginia | 214 | 38 | 16.1 | 3.9 | (8.5 – 23.7) | 176 | 83.9 | 3.9 | (76.3 – 91.5) |
Wisconsin | 185 | 20 | N/A | N/A | (N/A – N/A) | 165 | 88.7 | 4.3 | (80.3 – 97.1) |
37 state total | 10,077 | 1,345 | 14.5 | 1.2 | (12.1 – 16.9) | 8,732 | 85.5 | 1.2 | (83.1 – 87.9) |
Median | 12.6 | 86.1 | |||||||
Range | 8.6-20.7 | 75.6-92.8 |
1 Aged ≥ 18 years
2 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30